Dr. Sammons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3800Fax+1 617-632-1930
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2015 - 2018
University of MarylandResidency, Internal Medicine, 2012 - 2015
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2012
Certifications & Licensure
MA State Medical License 2022 - 2025
NC State Medical License 2018 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neoadjuvant Immunotherapy in Brain Metastases Start of enrollment: 2020 Nov 04
- Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib Start of enrollment: 2023 Mar 23
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- ASO Visual Abstract: Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients.Mahsa Taskindoust, Samantha M. Thomas, Sarah Sammons, Oluwadamilola M. Fayanju, Gayle DiLalla
Annals of Surgical Oncology. 2021-07-13 - 50 citationsHR+, HER2- Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles.Sarah Sammons, Donna L. Topping, Kimberly L. Blackwell
Current Cancer Drug Targets. 2017-08-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
